Skip to main content


COVID-19 vaccine trial from AstraZeneca, Oxford can resume in U.S.

By The Wall Street Journal  
   October 23, 2020

Federal health regulators have decided to allow the resumption of U.S. studies of a leading Covid-19 vaccine candidate from AstraZeneca PLC and the University of Oxford, according to a person familiar with the matter and materials reviewed by The Wall Street Journal.

Full story

Get the latest on healthcare leadership in your inbox.